Where can I learn more about this study?
You can find more information about this study on the websites listed below. If
more information about the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT03036150”
into the search box and click “Search”.
http://www.clinicaltrialsregister.eu. Once you are on the website, click “Home
•
and Search”, then type “2016-003896-24” in the search box, and click
“Search”.
www.AstraZenecaClinicalTrials.com. Once you are on the website, type
•
“D169AC00001” into the search box, and click “Find a Study”.
Full Study Title: A Study to Evaluate the Effect of Dapagliflozin on Renal
Outcomes and Cardiovascular Mortality in Patients with Chronic Kidney Disease.
AstraZeneca AB Protocol Number: D169AC00001
National Clinical Trials number: NCT03036150
EudraCT Number: 2016-003896-24
AstraZeneca AB sponsored this study and has its headquarters in Södertälje,
Sweden.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you
Participants in clinical studies belong to a large community of
people who take part in clinical research around the world.
They help researchers answer important health questions and
find medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research participation. CISCRP is not involved in recruiting
participants for clinical studies, nor is it involved in conducting clinical studies.
CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org
Version 1.0 2021_05_03
12 | Clinical Study Results